Max Planck group leader call for all fields of research.
Deadline: May 11.
https://www.mpg.de/career/max-planck-research-groups/applications
Paul Berg's obit in Science
"In the early 1970s, as the enzymology of DNA manipulation became available, Paul recognized that the DNA of SV40 and the DNA from bacteria or bacterial viruses could be joined to form hybrids or chimeric molecules—later known as recombinant molecules. The technology of making and manipulating such non-natural but extremely valuable molecules was called recombinant DNA technology."
"The prolific chemist, who has published a study every 37 hours this year, has been sanctioned by the University of Córdoba over his research work for other institutions in Russia and Saudi Arabia"
Competing for females can damage males' DNA. Study of #SeedBeetles suggests that the increased male investment in #SpermCompetition may lead to reduced #genetic quality in future generations. Mareike Koppik @JBaur_evo @DBergerBiol #PLOSBiology https://plos.io/3zviPCv
RT @HannoSeebens
Wow! This is a very strong argument for #doubleblind #academic #reviewing 👇
Analysing >3600 submissions in a randomised design revealed that the strong bias in favour of people from wealthy countries nearly vanished using double-blind reviews. Didn't expect such a strong effect https://twitter.com/Callomac/status/1643253382755528705
'Johnson & Johnson executives knew for decades about the risk of asbestos exposure linked to its talc products, including the famous baby powder it began selling 129 years ago. After years of pushing back on researchers and scientists, the company began facing a flood of lawsuits in recent years, along with government investigations and lawmaker inquiries.'
https://www.nytimes.com/2023/04/04/business/media/johnson-johnson-talc-settlement.html
T2 Phage by Madalena Parreira, a drawing for a piece I did on the Hershey-Chase experiments when I was at J Exp Med (for the short-lived JEM blog).
Nobelist Martin Chalfie on how *not* to apply for a postdoc:
"They say 'Here is my CV and I'd really like to work in your lab, do you have any space? That's a letter that could be sent out to a hundred people, or a thousand people. There's nothing in it."
Do you know someone looking for a Masters by Research? Likes fieldwork and ants? Part-funded MSci project on cooperation resource-sharing networks in wood ants, supervised by
@Adria & me, in collaboration with
@nationaltrust
https://findaphd.com/phds/project/self-funded-msc-by-research-project-cooperation-in-wood-ants-testing-quality-distance-trade-offs-in-resource-sharing-networks/?p156920
The #FENS2024 Programme Committee is waiting for your symposia and technical workshops! Don’t miss the opportunity to be part of Europe’s premier neuroscience conference (25-29 June 2024). Submit your proposal now 👉🏼 https://fensforum.org/proposal-submission/
Join us online next week as we celebrate the Grand Prize Winner (Aleksandar Obradovic) & finalists (Roser Vento-Tormo & Joshua Tan) of the 2023 Michelson Philanthropies & @sciencemagazine Prize for #Immunology!
Register here:
You can learn more about these three talented early-career immunologists & read their essays here:
Antigen independent metabolic effects of CAR constructs:
"Here we show that CARs differing only in the scFv reprogram T-cell metabolism differently. Even in the absence of antigens, some CARs increase proliferation and nutrient uptake in T cells."
#immunology #Preprint #Immunotherapy #CARTcells
'Deadline to apply has been extended to 15 April for EMBO Lecture Course Venice Summer School: The future of evolutionary-developmental systems biology 21 – 25 August 2023 in Venice, Italy'
'Countries negotiating a crucial treaty on pandemics at the World Health Organization have so far struggled to agree key points including the basic definition of a pandemic, despite targeting a rapid timetable for a deal in 2024'
https://www.ft.com/content/cbfe34be-2b76-4bf5-82cd-396e8695569d
Paul Berg's obit in Science
"In the early 1970s, as the enzymology of DNA manipulation became available, Paul recognized that the DNA of SV40 and the DNA from bacteria or bacterial viruses could be joined to form hybrids or chimeric molecules—later known as recombinant molecules. The technology of making and manipulating such non-natural but extremely valuable molecules was called recombinant DNA technology."
'Here’s the bottom line from it: “Mild Cognitively Impaired participants treated with anti-Aβ drugs were projected to have a material regression toward brain volumes typical of Alzheimer’s dementia ∼8 months earlier than if they were untreated.” I would say that if someone wants to make the argument that this is of no consequence (or perhaps even beneficial?) that they should step right up and have a crack at it. I (and many others) will watch with great interest. On the other hand, if the way of dealing with these findings is to pretend that they don’t exist, that is really unacceptable.'
An organoid model for thyroid cancer (#Preprint).
In our eighteenth 'Transitions in development' #interview, Cross-Title Reviews Editor Daniel Routledge speaks to Jingli Cao about his #career path, his experience of becoming a group leader and his love for #astronomy
22 years after publication of the human genome, we're still counting the genes. Nice overview by Amaral et al:
The status of the human gene catalogue https://arxiv.org/abs/2303.13996v1 #Genomics #bioinformatics
Check out our interview with Brent Foster, one of the Node correspondents. We find out about Brent’s research, science writing & what he’ll be blogging about on the Node.
https://thenode.biologists.com/meet-our-the-node-correspondents-brent-foster/news/
You can read Brent’s first post here:
https://thenode.biologists.com/if-you-give-a-scientist-a-cuttlefish/research/
All of the posts from our correspondents will appear on our dedicated topic page: https://thenode.biologists.com/the-node-correspondents/
I've worked on all of science, from B cells to T cells.
https://fellowsherpa.com